Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 2/20 | 0.50 |
| ▸ | SELP | P16109 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 4/20 | 0.48 |
| ▸ | CA9 | Q16790 | 4/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | FUT4 | P22083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29493314 | 1.00 | SELL (0.50) | SELLSELPCA12CA1CA2 | |
| SCHEMBL31674337 | 1.00 | SELL (0.50) | SELLSELPCA12CA1CA2 | |
| SCHEMBL27568982 | 0.88 | ALB (0.41) | SELLSELPCA12CA1CA2 | |
| SCHEMBL26309080 | 0.88 | HMGB1 (0.46) | SELLSELPCA12CA1CA2 | |
| SCHEMBL27610799 | 0.88 | PTPN1 (0.42) | SELLSELPCA12CA1CA2 | |
| SCHEMBL29607472 | 0.88 | ALB (0.41) | SELLSELPCA12CA1CA2 | |
| SCHEMBL18791245 | 0.84 | GAA (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6846496 | 0.83 | ACMSD (0.52) | SELLSELPCA12CA1CA2 | |
| SCHEMBL3517151 | 0.82 | SELL (0.58) | SELLSELPCA12CA1CA2 | |
| SCHEMBL30513844 | 0.82 | SELL (0.53) | SELLSELPCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260084136-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | FORMOSA PLASTICS CORP (TW) | 2026-03-26 | — | — | US | claimed |
| EP-4715000-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | Formosa Plastics Corporation (TW) | 2026-03-25 | — | — | EP | claimed |
| US-20250353791-A1 | CONCRETE MIXTURES AND METHODS OF MAKING THE SAME | UNIV ALABAMA (US) | 2025-11-20 | — | — | US | claimed |
| WO-2025111038-A1 | ACTIVATOR FOR PLAIN AND FOAMED EXOTHERMIC REACTION IN A WELLBORE | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119233943-A | Surface-treated boron nitride nanotubes and surface treatment method for boron nitride nanotubes | 耐尔泰科株式会社 | 2024-12-31 | — | — | CN | claimed |
| WO-2024242237-A1 | LITHIUM ION SECONDARY BATTERY | 내일테크놀로지 주식회사 | 2024-11-28 | — | — | WO | claimed |
| EP-3886600-B1 | METHOD FOR ELIMINATING DEFECTS IN POMEGRANATE JUICE BY MEANS OF ENZYMATIC PROCESSES | ANKARA UENIVERSITESI (TR) | 2024-10-09 | — | — | EP | claimed |
| WO-2024106592-A1 | SURFACE TREATED BORON NITRIDE NANOTUBE AND SURFACE TREATMENT METHOD FOR BORON NITRIDE NANOTUBE | 내일테크놀로지 주식회사 | 2024-05-23 | — | — | WO | claimed |
| US-20240158231-A1 | SURFACE-TREATED BORON NITRIDE NANO TUBE AND SURFACE TREATMENT METHOD OF BORON NITRIDE NANO TUBE | Naieel Technology Inc. (KR) | 2024-05-16 | — | — | US | claimed |
| WO-2023239561-A1 | CONCRETE MIXTURES AND METHODS OF MAKING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2023-12-14 | — | — | WO | claimed |
| US-20170112737-A1 | COSMETICS AND PHARMACEUTICAL APPLICATIONS OF GALLIC ACID AND GALLIC ACID DERIVATIVES | GREENPHARMA (FR) | 2017-04-27 | — | — | US | claimed |
| EP-2440301-B1 | METHOD FOR OBTAINING SECONDARY PLANT CONTENTS | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2013-11-06 | — | — | EP | claimed |
| US-8557304-B2 | Method of obtaining secondary plant constituents | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2013-10-15 | — | — | US | claimed |
| US-20120077994-A1 | METHOD OF OBTAINING SECONDARY PLANT CONSTITUENTS | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2012-03-29 | — | — | US | claimed |
| JP-2008513378-A | — | — | 2008-05-01 | — | — | JP | claimed |
| US-20080095866-A1 | delayed delivery of the polyphenol to keratinous tissues, such as skin, hair and nails, with enzymes of the keratinous tissue dephosphorylating the polyphenol, and returning it to its native active form | AJINOMOTO OMNICHEM S.A. (BE) | 2008-04-24 | — | — | US | claimed |
| WO-2007145395-A1 | METHOD OF STABILIZATION OF ACTIVE INGREDIENTS THAT HAVE LOW SOLUBILITY, USING HOLLOW TYPE MULTI-LAYERED MICROCAPSULE MADE OF HYDROPHOBIC POLYMER/POLYHYDRIC ALCOHOLS AND PREPARATION METHOD THEREOF, AND COSMETIC COMPOSITION CONTAINING THE MICROCAPSULES | HAN-BUL COSMETICS CO., LTD. (KR) | 2007-12-21 | — | — | WO | claimed |
| EP-1799228-A1 | TOPICAL COMPOSITIONS CONTAINING PHOSPHORYLATED POLYPHENOLS | Ajinomoto Omnichem S.A. (BE) | 2007-06-27 | — | — | EP | claimed |
| WO-2006029484-A1 | TOPICAL COMPOSITIONS CONTAINING PHOSPHORYLATED POLYPHENOLS | AJINOMOTO OMNICHEM S.A. (BE) | 2006-03-23 | — | — | WO | claimed |
| EP-0691886-B1 | MICROCAPSULES WITH WALLS MADE OF CROSS-LINKED PLANT POLYPHENOLS, AND COMPOSITIONS CONTAINING SAME | CENTRE NAT RECH SCIENT (FR) | 1999-04-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260084136-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | TAS2R40, SI, FTO | SELL 342/4885SELP 130/4885CA12 795/4885 |
| US-20080095866-A1 | delayed delivery of the polyphenol to keratinous tissues, such as skin, hair and nails, with enzymes of the keratinous tissue dephosphorylating the polyphenol, and returning it to its native active form | KRT18, DUSP6, PPP5C | SELL 4636/4885SELP 3568/4885CA12 3624/4885 |
| US-20170112737-A1 | COSMETICS AND PHARMACEUTICAL APPLICATIONS OF GALLIC ACID AND GALLIC ACID DERIVATIVES | CUTA, GANAB, TYR | SELL 3948/4885SELP 3816/4885CA12 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.